Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209661

BONJESTA (DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE)
20MG;20MG Marketing Status: Prescription

Active Ingredient: DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Proprietary Name: BONJESTA
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 20MG;20MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209661
Product Number: 001
Approval Date: Nov 7, 2016
Applicant Holder Full Name: DUCHESNAY INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English